Navigation Links
MedVantx Launches Patient Profile™, A Proprietary Closed-Loop Pharmaceutical Adherence Management Program for Medical Home, Accountable Care and Population Health Management
Date:11/22/2011

SAN DIEGO, Nov. 22, 2011 /PRNewswire/ -- MedVantx, Inc., today announced the deployment of its patent pending Patient Profile™ patient medication and adherence reporting engine across its network of 3,600 high prescribing primary care providers participating in the Company's integrated program of initial free medication therapy, adherence management and home delivery program. This new program utilizes the Company's proprietary automated ATM like sample management system ("MedStart") and an integrated secure web reporting portal to provide physicians visibility to their patients' adherence to chronic medication therapy.  The Platform is designed to help leading medical groups meet the requirements of emerging healthcare reform platforms.

Researchers at Harvard University, Brigham and Women's Hospital and CVS/Caremark announced the results of an important study last week indicating that up to 24% of consumers never fill their initial prescription. "While the results of this study are consistent with previous studies in the area, what is interesting is that prescription abandonment rates appear to be increasing with the growth in electronic prescribing," said Susan Hogue, VP of Managed Care Networks and Clinical Services at MedVantx.  "As Physicians embrace EHR and e-prescribing platforms, they need new tools to help insure medication therapy is initiated and adhered to on an ongoing basis.  Today, physicians have limited access to detailed data about medication samples provided and actual prescriptions filled.  MedVantx has pioneered a program that enables physicians to start all their patients on free prescription medications at the point of care thereby eliminating the potential for abandonment. As a result MedVantx is in a unique position to deliver a complete view of a specific patient's medication program from an initial medication sample to continued fulfillment of chronic medications."

MedVantx provides physicians with first ever access to a comprehensive formulary of free generic, brand, and over-the-counter medications covering chronic and complex conditions through its MedStart™ system. The MedStart™ system automates the traditional sampling process for the physician; captures physician sampling data for inclusion in the patients' claims history medical record and provides consumers access to highly relevant drug and disease state educational materials. Since patients don't always get prescriptions filled, physicians can enhance adherence by providing their patients with initial therapy and better informational tools to manage their conditions right from the office.  MedVantx also reaches out to patients to provide drug information, discuss adherence related issues and offer low-cost home delivery options.

Now with the availability of the MedVantx Patient Profile™, physicians are able to view data about how patients, on an individual basis, are complying with their prescribed medication treatments.  By showing exactly when a patient fills prescriptions, physicians can detect late refills, gaps in medication fulfillment, discontinued treatments and more to accurately access and improve patient compliance.

About MedVantx, Inc.

MedVantx is an innovative consumer medication management and delivery company committed to streamlining access, reducing costs and providing highly relevant information to benefit patients, physicians, health plans, employers and manufacturers.  The MedVantx platform is a fully automated / integrated point of care to consumer home delivery channel focused on increasing the quality and cost effectiveness of the last non-managed pharmaceutical channel - the physician's office sample closet.  The Company's consumer medication management platform includes free initial prescription and over-the-counter medication therapy at the point of care; a consumer helpline providing drug information, adherence management and reimbursement assistance and convenient consumer home delivery through its mail order pharmacy. The national MedVantx network has served over 2.5 million consumers through an integrated network including 16 health plans, 18 manufacturers and more than 3,600 prescribers.

For additional information about MedVantx and opportunities to participate in MedVantx Network, please contact MedVantx, Inc. at (858) 625-2990.

MedVantx Contact:
Susan Hogue
(858) 625-2990 Ext. 142 susan.hogue@medvantx.com


'/>"/>
SOURCE MedVantx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedVantx and Blue Cross & Blue Shield of Rhode Island Partner to Provide Physicians with Integrated Medication Management Platform in Newly Created Patient-Centered Medical Homes
2. MedVantx Honored by Inc. 500/5000 Three Years in a Row
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
5. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
6. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
9. Premier Micronutrient Launches Supplement for Hearing Health
10. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
11. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... YORK , December 2, 2016 ... the trading session in red, while the Dow Jones Industrial ... at the close of US markets, which prompted Stock-callers this ... stocks: NuVasive Inc. (NASDAQ: NUVA ), Smith & ... (NASDAQ: NXTM ), and Cesca Therapeutics Inc. (NASDAQ: ...
(Date:12/2/2016)... LONDON , Dec. 1, 2016 Around ... every country, region and each habitable land present over ... haunt every individual once in a life time this ... proper care available until now. Given the steady increase ... mortality, together with the spiraling healthcare costs of treatment, ...
(Date:11/30/2016)... Research and Markets has announced the addition ... - MedCore" report to their offering. ... , , The cerebrospinal fluid ... healthy individuals, it is circulated though the brain and its ventricles, the ... of CSF surrounding the brain changes significantly. As ...
Breaking Medicine Technology:
(Date:11/30/2016)... ... November 30, 2016 , ... "I hate when the mixture ... brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that there had ... handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and toothpaste from ...
(Date:11/30/2016)... FL (PRWEB) , ... November 30, 2016 , ... ... disorder and mental health treatment has announced the opening of a new eating ... partial hospitalization and intensive outpatient treatment for adults and adolescents, both males and ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... injured workers have been a focus of public policymakers and system stakeholders in ... Institute (WCRI) released its Medical Price Index for Workers’ Compensation, Eighth Edition ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... clinical research community that the FDA Binding Guidance goes into effect next month. ... formats listed in the FDA Data Standards Catalog. The current FDA Data Standards ...
(Date:11/30/2016)... ... 2016 , ... U.S. Security Associates (USA) announced the acquisition ... Richmond, Virginia. The acquisition further strengthens USA’s capabilities within the expanding healthcare ... prides itself on 100% client-retention to the healthcare industry. In addition, ODS has ...
Breaking Medicine News(10 mins):